Avalo Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Avalo Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2013 to 2023.
  • Avalo Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $35.9M.
  • Avalo Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $54.9M.
  • Avalo Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$4.18M, a 0.26% increase from 2022.
  • Avalo Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$4.19M, a 73.8% decline from 2021.
  • Avalo Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$2.41M, a 143% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$4.18M +$11K +0.26% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 -$4.19M -$1.78M -73.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 -$2.41M -$8.08M -143% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $5.67M +$5.52M +3755% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $147K +$92K +168% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-08
2018 $54.9K +$109K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 -$53.6K +$338K +86.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 -$392K -$911K -175% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $520K -$540K -51% Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
2014 $1.06M +$1.17M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-14
2013 -$111K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.